NCT02348918: A trial that was reported late by Allegro Ophthalmics, LLC
This trial has reported, although it was 107 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02348918 |
|---|---|
| Title | A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 13, 2014 |
| Completion date | May 16, 2017 |
| Required reporting date | May 16, 2018, midnight |
| Actual reporting date | Aug. 31, 2018 |
| Date last checked at ClinicalTrials.gov | Oct. 27, 2025 |
| Days late | 107 |